地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:13212737804
传真:17754422825
邮箱:sales@amyjet.com

美国Plant Cell Technology公司为商业及研究用植物组织培养实验室和植物种植者开发、生产了旗舰产品PPM™ (Plant Preservative Mixture),它是一种广谱抗微生物剂,可以杀死细菌和真菌细胞,防止真菌孢子的萌发,并在较高浓度下能消除内源性污染的外植体。研究表明PPM™活性成分可以渗透过真菌或细菌细胞壁,抑制柠檬酸循环和电子传递链等中心代谢循环中的关键酶的活性,并且可以抑制培养基中的单糖和氨基酸向真菌和细菌细胞的运输。PPM™能有效地抑制植物细胞和植物组织培养中的通过空气、水、人传播的微生物污染及内源性污染,而不会影响体外种子发芽、愈伤组织增殖和愈伤组织的再生。并且,PPM™具有热稳定性,可以和培养基一起灭菌,同时比常用抗生素价更低廉,可以作为植物组织培养基的标准成分。
The principal PCT scientist involved in the development of the PPM™ application is Dr. Assaf Guri. Dr. Assaf Guri holds degrees in genetics, applied genetics and plant breeding from the Hebrew University in Jerusalem and Michigan State University in the US. Before joining Plant Cell Technology, Inc., Dr. Guri worked with the Volcani Agricultural Research Center in Israel, Michigan State University in East Lansing, Michigan and DNAP in New Jersey.
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

Accurate Chemical & Scientific Corporation公司成立于1974年,标准化流程生产高质量多克隆和单克隆抗体。公司市场覆盖广泛客户群体和应用领域,未政府实验室、大学研究中心、制药实验室以及医院临床中心服务。
1974 saw the incorporation of Accurate Chemical & Scientific Corporation. Accurate pioneered and introduced standardized, highly characterized polyclonal and monoclonal antibodies. Since 1975, Accurate has specialized in products for basic and R&D research as well as routine laboratory work. Accurate's market covers a broad range of customers and applications, serving government labs, university research centers, pharmaceutical laboratories, as well as hospitals, clinical and industrial centers.
Accurate chemical公司的主要产品包括:
Antibodies and Antigens
Monoclonal antibodies
Polyclonal antibodies
Lab Equipment
Biocolor Assay Kits
Cell Separation Media
" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Accurate Chemical"> Accurate Chemical
GATTA quant有限公司成立于2014年,专注于超高分辨系统中探针的研制,使实验快速、简便、准确。这些探针通过使用特殊的纳米结构,即所谓DNA折纸技术精确定位放置染料分子,可使你测定的显微结果达到几纳米的分辨精度。为确保最优效果和性能,公司会根据您的意愿、要求和意图单独设计定制产品。
Gattaquant的主要产品包括:

GATTA-BEADS

GATTA-BEADS W
<<<
GATTA-CELLS:
GATTA-CELLS
GATTA-CELLS NIR

GATTA-SIM NANORULER

GATTA-STED NANORULER:
GATTA-STED NANORULER
GATTA-STED 3D NANORULER

GATTA-CONFOCAL NANORULER
Localization Based:
GATTA-PAINT HIRES
GATTA-PAINT NANORULER
GATTA-PAINT 3D – EXPERT AND ULTIMATE LINE
GATTA-STORM NANORULER

GATTA-AFM:
GATTA-AFM
GATTA-AFM 3D NANORULER

GATTA-GOLD
<<<<
GOLD NANOHELICES (L/R)

DNA-PAINT STARTER KIT
GATTAQUANT PRODUCT LEGACY
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="GATTA quant"> GATTA quant
艾美捷科技代理Nebulabio全系列药合成、递送及点击化学产品。
北京辰辉创聚生物技术有限公司(Nebula Biotechnology Co., Ltd.)是一家专注于创新药物研发关键试剂研发的高科技企业。自2022年成立以来,已推出药物标准品系列产品、抗体药参比试剂系列产品、活性小分子系列产品。公司已和全球近50家制药公司、药物研发机构、诊断试剂产品公司建立了友好的业务合作关系。
产品列表如下,欢迎咨询。
| 产品名称 | 货号 | 规格 | CAS号 |
| trans-Cyclooct-4-en-L-Lysine (EQUATORIAL) | NBS-230715 | 500mg; 1g | 1380349-88-1 |
| PrDiAzK | NBS-230716 | 100mg; 1g | 2231405-64-2 |
| exo-BCN-Fmoc-L-Lysine (BCN) | NBS-230717 | 500mg; 1g | 1493802-76-8 |
| DiAzK | NBS-230718 | 100mg; 1g | 1253643-88-7 |
| N3-Lys | NBS-230719 | 1g; 5g | 1167421-25-1 |
| cyclopropene-L-Lysine (CP) | NBS-230720 | 500mg; 1g | 1610703-09-7 |
| endo-BCN-Fmoc-L-Lysine (BCN) | NBS-230721 | 500mg; 1g | 1493802-95-1 |
| trans-Cyclooct-2-en-L-Lysine (TCO*A) | NBS-230722 | 500mg; 1g | 1801936-26-4 |
| exo BCN-L-Lysine | NBS-230723 | 500mg; 1g | 1384100-45-1 |
| Norbonene-CH2-L-Lysine (NBO) | NBS-230724 | 500mg | 1378916-76-7 (H+) |
| rac BCN-L-Lysine | NBS-230725 | 500mg; 1g; 5g | N/A |
| trans-Cyclooct-4-en-L-Lysine (AXIAL) | NBS-230726 | 500mg; 1g | 1380349-88-1 |
| endo BCN-L-Lysine | NBS-230727 | 500mg; 1g | 1493802-96-2 / 1580501-90-1 |
| PrK -HCl-salt | NBS-230728 | 1g; 5g | 1215204-46-8 (H+) // 1428330-91-9 (HCl) |
| SCO-L-Lysine-HCO2H-salt (purity 99%) | NBS-230729 | 10mg | 1309581-49-4 |
| SCO-L-Lysine-HCO2H-salt (purity 95%) | NBS-230730 | 500mg; 1g; 5g | 1309581-49-4 |
| TCO*A-OH (AXIAL) | NBS-230731 | 100mg; 1g | 1414375-00-0 |
| Me-Tet-PEG2-NH2 | NBS-230732 | 100mg; 500mg | N/A |
| Coumarin-PEG4-Tetrazine | NBS-230734 | 1mg; 5mg | N/A |
| Coumarin-C2-exoBCN | NBS-230735 | 1mg; 5mg | 2488174-17-8 |
| Coumarin-C2-TCO (axial) | NBS-230736 | 1mg; 5mg | 2488174-16-7 |
| (E)-cyclooctene doxorubicin conjugate (axial) | NBS-230738 | 10mg | 1438387-95-1 |
| SCO-NHS carbonate | NBS-230739 | 100mg; 1g | N/A |
| exo-BCN-NHS carbonate | NBS-230740 | 500mg; 1g | 1493802-77-9 |
| endo-BCN-NHS carbonate | NBS-230741 | 500mg; 1g | 1426827-79-3 |
| TCO4-NHS carbonate (EQUATORIAL) | NBS-230742 | 500mg; 1g | 1191901-33-3 |
| TCO4-NHS carbonate (AXIAL) | NBS-230743 | 500mg; 1g | 1191901-33-3 |
| TCO*-NHS carbonate (EQUATORIAL) | NBS-230744 | 500mg; 1g | 1610931-22-0 |
| TCO*-NHS carbonate (AXIAL) | NBS-230745 | 100mg; 1g | 1610931-22-0 |
| Tetrazine-Amine-TFA-salt | NBS-230746 | 100mg; 500mg | 1092689-33-2 |
| TCO*E-active ester (p-NPC, equatorial) | NBS-230747 | 100mg; 1g | 1580501-97-8 |
| exo BCN-OH | NBS-230850 | 500mg; 1g | 1263291-41-3 |
| SCO-active ester (p-NPE) | NBS-230851 | 500mg; 1g | 1309581-51-8 |
| SCO-OH | NBS-230852 | 500mg; 1g | 29916-92-5 |
| endo BCN-OH | NBS-230853 | 500mg; 1g | 1263166-90-0 |
| Aminopentyl-Tetrazine-HCl-salt | NBS-230854 | 100mg; 500mg | N/A |
| (E)-cyclooctene doxorubicin conjugate (EQUATORIAL) | NBS-230855 | 10mg | 1438387-96-2 |
| (E)-cyclooct-4-enol / equatorial-TCO / E | NBS-230856 | 100mg; 1g | 39637-79-1 |
| (E)-cyclooct-4-en active ester / TCO/E- active ester (p-NPE) (EQUATORIAL) | NBS-230857 | 100mg; 1g | 1354323-64-0 |
| (E)-cyclooct-4-en active ester / TCO4 / A- active ester (p-NPE) (AXIAL) | NBS-230858 | 100mg; 1g | 1438415-89-4 |
| (E)-cyclooct-4-enol / axial -TCO4 / A | NBS-230859 | 100mg; 1g | 39637-78-0 |
| Tetrazine active ester (Tetrazine-NHS) | NBS-230860 | 100mg; 500mg | 1384271-41-3 |
| Aminopropyl-Tetrazine-HCl-salt | NBS-230861 | 100mg; 500mg | 1146968-37-7 (H+) |
| N-Trifluoro-Acetylpropargylamine | NBS-230862 | 1g; 5g | 14719-21-2 |
| Methyl-Tetrazine-Amine- HCO2H-salt | NBS-230863 | 100mg; 500mg | 1345955-28-3 (H) |
| Tetrazine-Amine-HCO2H-salt | NBS-230864 | 100mg; 500mg | 1092689-33-2 (H) |
| TCO*A-OH (EQUATORIAL) | NBS-230865 | 100mg; 1g | 93301-75-8 |
| BCN-3,5-diene-9-methanol | NBS-230866 | 500mg; 1g | 1072439-47-4 |
| TCO*A-active ester (p-NPE) | NBS-230867 | 100mg; 1g | 1580501-97-8 |
| exo BCN-active ester (p-NPE) | NBS-230868 | 500mg | 1380006-72-3 |
| endo BCN-active ester (p-NPE) | NBS-230869 | 500mg; 1g | 1263166-91-1 |
| 12-Azidododecanoic acid | NBS-230876 | 100mg | 80667-36-3 |
| EdU | NBS-230877 | 100mg | 61135-33-9 |
| Pr-DiAz-OH | NBS-230878 | 100mg; 500mg | 1450754-41-2 |
| Pr-DiAz-NHSC | NBS-230879 | 100mg; 500mg | 2488239-96-7 |
| DiAz-NHSE | NBS-230880 | 100mg; 500mg | 1239017-80-1 |
| Pr-DiAz-NHSE | NBS-230881 | 100mg; 500mg | 2012552-32-6 |
| Pr-DiAz-COOH | NBS-230882 | 100mg; 500mg | 1450754-37-6 |
| Pr-DiAz-NH2 | NBS-230883 | 100mg; 500mg | 1450752-97-2 |
| Coumarin-PEG8-Tetrazine | NBS-230884 | 1mg; 5mg | N/A |
| Coumarin-PEG3-TCO* (AXIAL) | NBS-230885 | 1mg; 5mg | 2488319-02-2 |
| Coumarin-PEG7-TCO* (AXIAL) | NBS-230886 | 1mg; 5mg | N/A |
| Coumarin-PEG2-TCO* (AXIAL) | NBS-230891 | 1mg; 5mg | 2488174-19-0 |
| Coumarin-PEG2-exoBCN | NBS-230892 | 1mg; 5mg | 2488174-18-9 |
| Coumarin-PEG2-SCO | NBS-230893 | 1mg; 5mg | 2488239-94-5 |
| Coumarin-PEG2-endoBCN | NBS-230894 | 1mg; 5mg | 2488174-18-9 |
| Biotin-PEG3-CoenzymeA | NBS-230895 | 100µg; 1mg | N/A |
| Bis-Cyano-PEG9 | NBS-230896 | 100mg; 500mg | 41263-81-4 |
| Bis-Cyano-PEG5 | NBS-230897 | 100mg; 500mg | 41263-79-0 |
| Bis-Cyano-PEG4 | NBS-230898 | 100mg; 500mg | 57741-46-5 |
| N3-PEG8-t-butyl ester | NBS-230899 | 100mg; 1g | 1623791-99-0 |
| N3-PEG5-t-butyl ester | NBS-230900 | 100mg; 1g | 1415800-41-7 |
| N3-PEG4-t-butyl ester | NBS-230901 | 100mg; 1g | 581066-04-8 |
| N3-PEG3-t-butyl ester | NBS-230902 | 100mg; 1g | 252881-73-5 |
| Boc-N-Amido-PEG7-N3 | NBS-230903 | 100mg; 500mg | 206265-96-5 |
| Boc-N-Amido-PEG3-N3 | NBS-230904 | 100mg; 500mg | 642091-68-7 |
| Boc-N-Amido-PEG2-N3 | NBS-230905 | 100mg; 500mg | 950683-55-3 |
| Boc-N-Amido-PEG4-Alkyne | NBS-230906 | 100mg; 500mg | 1219810-90-8 |
| Boc-N-Amido-PEG3-Alkyne | NBS-230907 | 100mg; 500mg | 1333880-60-6 |
| Fluorescent-PEG8-Me-Tet | NBS-230908 | 5mg; 25mg | N/A |
| Fluorescent-PEG4-Me-Tet | NBS-230909 | 5mg; 25mg | N/A |
| Fluorescent-PEG3-Me-Tet | NBS-230910 | 5mg; 25mg | N/A |
| TAMRA-PEG8-Alkyne | NBS-230911 | 5mg; 25mg | N/A |
| TAMRA-PEG4-Alkyne | NBS-230912 | 5mg; 25mg | 1225057-68-0 |
| TAMRA-PEG3-Alkyne | NBS-230913 | 5mg; 25mg | N/A |
| TAMRA-PEG7-N3 | NBS-230914 | 5mg; 25mg | N/A |
| TAMRA-PEG3-N3 | NBS-230915 | 5mg; 25mg | 1228100-59-1 |
| TAMRA-PEG2-N3 | NBS-230916 | 5mg; 25mg | N/A |
| TAMRA-PEG8-COOH | NBS-230917 | 5mg; 25mg | N/A |
| TAMRA-PEG4-COOH | NBS-230918 | 5mg; 25mg | N/A |
| TAMRA-PEG3-COOH | NBS-230919 | 5mg; 25mg | N/A |
| TAMRA-PEG8-NHS | NBS-230920 | 5mg; 25mg | 2067281-44-9 |
| TAMRA-PEG4-NHS | NBS-230921 | 5mg; 25mg | N/A |
| TAMRA-PEG3-NHS | NBS-230922 | 5mg; 25mg | N/A |
| TAMRA-PEG7-Maleimide | NBS-230923 | 5mg; 25mg | N/A |
| TAMRA-PEG3-Maleimide | NBS-230924 | 5mg; 25mg | N/A |
| TAMRA-PEG2-Maleimide | NBS-230925 | 5mg; 25mg | N/A |
| TAMRA-PEG7-NH2 | NBS-230926 | 5mg; 25mg | N/A |
| TAMRA-PEG3-NH2 | NBS-230927 | 5mg; 25mg | N/A |
| TAMRA-PEG2-NH2 | NBS-230928 | 5mg; 25mg | 1425379-69-6 |
| Me-Tet-PEG8-NHBoc | NBS-230929 | 100mg; 500mg | 2143968-21-0 |
| Me-Tet-PEG4-NHBoc | NBS-230930 | 100mg; 500mg | 2143955-71-7 |
| Me-Tet-PEG3-NHBoc | NBS-230931 | 100mg; 500mg | 2141976-32-9 |
| Biotin-PEG8-Me-Tet | NBS-230932 | 100mg; 500mg | 2143958-82-9 |
| Biotin-PEG4-Me-Tet | NBS-230933 | 100mg; 500mg | 1962919-31-8 |
| Biotin-PEG3-Me-Tet | NBS-230934 | 100mg; 500mg | 2143968-06-1 |
| Me-Tet-PEG9-COOH | NBS-230935 | 100mg; 500mg | 2143964-70-7 |
| Me-Tet-PEG5-COOH | NBS-230936 | 100mg; 500mg | 2143964-72-9 |
| Me-Tet-PEG4-COOH | NBS-230937 | 100mg; 500mg | 2141976-30-7 |
| Me-Tet-PEG9-NHS | NBS-230938 | 100mg; 500mg | 2143955-78-4 |
| Me-Tet-PEG5-NHS | NBS-230939 | 100mg; 500mg | 2096446-25-0 |
| Me-Tet-PEG4-NHS | NBS-230940 | 100mg; 500mg | 2143968-22-1 |
| Me-Tet-PEG8-Maleimide | NBS-230941 | 100mg; 500mg | 2143968-05-0 |
| Me-Tet-PEG4-Maleimide | NBS-230942 | 100mg; 500mg | 1715913-76-0 |
| Me-Tet-PEG3-Maleimide | NBS-230943 | 100mg; 500mg | 2141976-31-8 |
| Me-Tet-PEG8-NH2-HCl salt | NBS-230944 | 100mg; 500mg | 2143958-58-9 (H+) |
| Me-Tet-PEG4-NH2 | NBS-230945 | 100mg; 500mg | 2055646-21-2 |
| Me-Tet-PEG3-NH2 | NBS-230946 | 100mg; 500mg | 2141976-28-3 |
| Biotin-PEG8-Alkyne | NBS-230947 | 100mg; 500mg | 2143968-80-1 |
| Biotin-PEG4-Alkyne | NBS-230948 | 100mg; 500mg | 1262681-31-1 |
| Biotin-PEG3-Alkyne | NBS-230949 | 100mg; 500mg | 1421701-68-9 |
| Biotin-PEG7-N3 | NBS-230950 | 100mg; 500mg | 1334172-75-6 |
| Biotin-PEG3-N3 | NBS-230951 | 100mg; 500mg | 875770-34-6 |
| Biotin-PEG2-N3 | NBS-230952 | 100mg; 500mg | 945633-30-7 |
| Biotin-PEG8-COOH | NBS-230953 | 100mg; 500mg | 2143964-62-7 |
| Biotin-PEG4-COOH | NBS-230954 | 100mg; 500mg | 721431-18-1 |
| Biotin-PEG3-COOH | NBS-230955 | 100mg; 500mg | 252881-76-8 |
| Biotin-PEG8-NHS | NBS-230956 | 100mg; 500mg | 2143968-03-8 |
| Biotin-PEG4-NHS | NBS-230957 | 100mg; 500mg | 459426-22-3 |
| Biotin-PEG3-NHS | NBS-230958 | 100mg; 500mg | 1253286-56-4 |
| Biotin-PEG7-Maleimide | NBS-230959 | 100mg; 500mg | 1898221-65-2 |
| Biotin-PEG3-Maleimide | NBS-230960 | 100mg; 500mg | 1431618-70-0 |
| Biotin-PEG2-Maleimide | NBS-230961 | 100mg; 500mg | 305372-39-8 |
| Biotin-PEG7-NH2 | NBS-230962 | 100mg; 500mg | 1334172-76-7 |
| Biotin-PEG3-NH2 | NBS-230963 | 100mg; 500mg | 359860-27-8 |
| Biotin-PEG2-NH2 | NBS-230964 | 100mg; 500mg | 138529-46-1 |
| TCO4-PEG8-COOH | NBS-230965 | 100mg; 500mg | N/A |
| TCO*-PEG8-COOH | NBS-230966 | 100mg; 500mg | N/A |
| TCO*-PEG4-COOH | NBS-230967 | 100mg; 500mg | N/A |
| TCO4-PEG4-COOH | NBS-230968 | 100mg; 500mg | 1802913-21-8 |
| TCO4-PEG3-COOH | NBS-230969 | 100mg; 500mg | 2141981-86-2 |
| TCO*-PEG3-COOH | NBS-230970 | 100mg; 500mg | N/A |
| TCO*-PEG8-NHS | NBS-230971 | 100mg; 500mg | N/A |
| TCO4-PEG8-NHS | NBS-230972 | 100mg; 500mg | N/A |
| TCO4-PEG4-NHS | NBS-230973 | 100mg; 500mg | 1621096-79-4 |
| TCO*-PEG4-NHS | NBS-230974 | 100mg; 500mg | N/A |
| TCO*-PEG3-NHS | NBS-230975 | 100mg; 500mg | N/A |
| TCO4-PEG3-NHS | NBS-230976 | 100mg; 500mg | 2141981-88-4 |
| TCO*-PEG7-Maleimide | NBS-230977 | 100mg; 500mg | N/A |
| TCO*-PEG3-Maleimide | NBS-230978 | 100mg; 500mg | 2392039-23-3 |
| TCO*-PEG2-Maleimide | NBS-230979 | 100mg; 500mg | N/A |
| TCO4-PEG7-Maleimide | NBS-230980 | 100mg; 500mg | N/A |
| TCO4-PEG3-Maleimide | NBS-230981 | 100mg; 500mg | 1914971-04-2 |
| TCO4-PEG2-Maleimide | NBS-230982 | 100mg; 500mg | 2141981-85-1 |
| TCO*-PEG2-NH2 | NBS-230983 | 100mg; 500mg | N/A |
| TCO*-PEG3-NH2 | NBS-230984 | 100mg; 500mg | N/A |
| TCO*-PEG7-NH2 | NBS-230985 | 100mg; 500mg | N/A |
| TCO4-PEG7-NH2 | NBS-230986 | 100mg; 500mg | N/A |
| TCO4-PEG3-NH2 | NBS-230987 | 100mg; 500mg | 1800507-93-0 |
| TCO4-PEG2-NH2 | NBS-230988 | 100mg; 500mg | N/A |
| SCO-PEG7-Maleimide | NBS-230989 | 100mg; 500mg | 2143968-81-2 |
| SCO-PEG3-Maleimide | NBS-230990 | 100mg; 500mg | 2141976-35-2 |
| SCO-PEG2-Maleimide | NBS-230991 | 100mg; 500mg | 2141976-23-8 |
| BCN-exo-PEG7-Maleimide | NBS-230992 | 100mg; 500mg | N/A |
| BCN-exo-PEG3-Maleimide | NBS-230993 | 100mg; 500mg | N/A |
| BCN-exo-PEG2-Maleimide | NBS-230994 | 100mg; 500mg | 2141976-22-7 |
| BCN-endo-PEG7-Maleimide | NBS-230995 | 100mg; 500mg | N/A |
| BCN-endo-PEG3-Maleimide | NBS-230996 | 100mg; 500mg | 2141976-33-0 |
| BCN-endo-PEG2-Maleimide | NBS-230997 | 100mg; 500mg | N/A |
| BCN-exo-PEG8-COOH | NBS-230998 | 100mg; 500mg | N/A |
| BCN-exo-PEG4-COOH | NBS-230999 | 100mg; 500mg | 1421932-54-8 |
| BCN-exo-PEG3-COOH | NBS-231000 | 100mg; 500mg | 1807501-82-1 |
| BCN-exo-PEG8-NHS | NBS-231001 | 100mg; 500mg | N/A |
| BCN-exo-PEG4-NHS | NBS-231002 | 100mg; 500mg | N/A |
| BCN-exo-PEG3-NHS | NBS-231003 | 100mg; 500mg | 2101206-94-2 |
| BCN-endo-PEG3-NHS | NBS-231004 | 100mg; 500mg | 2101206-94-2 |
| BCN-endo-PEG4-NHS | NBS-231005 | 100mg; 500mg | 1702356-19-1 |
| BCN-endo-PEG8-NHS | NBS-231006 | 100mg; 500mg | 1608140-48-2 |
| BCN-endo-PEG8-COOH | NBS-231007 | 100mg; 500mg | N/A |
| BCN-endo-PEG4-COOH | NBS-231008 | 100mg; 500mg | 1881221-47-1 |
| BCN-endo-PEG3-COOH | NBS-231009 | 100mg; 500mg | 1807501-82-1 |
| SCO-PEG3-COOH | NBS-231010 | 100mg; 500mg | 2141976-36-3 |
| SCO-PEG4-COOH | NBS-231011 | 100mg; 500mg | 2141976-27-2 |
| SCO-PEG8-COOH | NBS-231012 | 100mg; 500mg | 2143968-79-8 |
| SCO-PEG8-NHS | NBS-231013 | 100mg; 500mg | 2143968-68-5 |
| SCO-PEG4-NHS | NBS-231014 | 100mg; 500mg | 2141976-26-1 |
| SCO-PEG3-NHS | NBS-231015 | 100mg; 500mg | 2141976-25-0 |
| SCO-PEG7-NH2 | NBS-231016 | 100mg; 500mg | 2141976-35-2 |
| SCO-PEG3-NH2 | NBS-231017 | 100mg; 500mg | 2141976-29-4 |
| SCO-PEG2-NH2 | NBS-231018 | 100mg; 500mg | 2141976-34-1 |
| BCN-exo-PEG2-NH2 | NBS-231019 | 100mg; 500mg | 1357379-13-5 |
| BCN-exo-PEG3-NH2 | NBS-231020 | 100mg; 500mg | 1841134-72-2 |
| BCN-exo-PEG7-NH2 | NBS-231021 | 100mg; 500mg | 2143968-34-5 |
| BCN-endo-PEG7-NH2 | NBS-231022 | 100mg; 500mg | 2143968-34-5 |
| BCN-endo-PEG3-NH2 | NBS-231023 | 100mg; 500mg | 1883512-27-3 |
| BCN-endo-PEG2-NH2 | NBS-231024 | 100mg; 500mg | 1263166-93-3 |
| PEG-12 | NBS-231025 | 1g; 10g; bulk | 6790-09-6 |
| PEG-11 | NBS-231026 | 1g; 10g; bulk | 6809-70-7 |
| PEG-10 | NBS-231027 | 1g; 10g; bulk | 5579-66-8 |
| PEG-9 | NBS-231028 | 1g; 10g; bulk | 3386-18-3 |
| PEG-8 | NBS-231029 | 1g; 10g; 100g; 1kg; bulk | 5117-19-1 |
| Alkyne-PEG2-TCA | NBS-231030 | 100mg | 1281695-03-1 |
| Azido-PEG2-TCA | NBS-231031 | 100mg | 1281695-02-0 |
| Alkyne-PEG2-CM | NBS-231032 | 100mg | 1281695-01-9 |
| Azido-PEG2-CM | NBS-231033 | 100mg | 1281695-00-8 |
| Alkyne-PEG2 | NBS-231034 | 100mg | 7218-43-1 |
| Azido-PEG1 | NBS-231035 | 100mg | 139115-90-5 |
| 2-Methyl-Glycerol | NBS-231036 | 10g; 100g | 25245-58-3 |
| 2-Stearoyl glycerol | NBS-231037 | 20mg; 100mg | 621-61-4 |
| 2-Palmitoyl glycerol | NBS-231038 | 20mg; 100mg | 23470-00-0 |
| 2-Myristoyl glycerol | NBS-231039 | 20mg; 100mg | 3443-83-2 |
| 2-Lauroyl glycerol | NBS-231040 | 20mg; 100mg | 1678-45-1 |
| 2-Linoleoyl glycerol | NBS-231041 | 100 mmol solution in ACN | 3443-82-1 |
| 2-Oleoyl-glycerol | NBS-231042 | 10mg; 100mg | 3443-84-3 |
| SH-6 | NBS-231043 | 1mg; 5mg | 701976-55-8 |
| SH-5 | NBS-231044 | 1mg; 5mg | 701976-54-7 |
| Ins(345)P3*3Na | NBS-231045 | 1mg | 112791-62-5 (H) / 911105-38-9 (6 Na) |
| Ins(1)P*2K | NBS-231046 | 5mg | 313263-16-0 / 15421-51-9 (H) |
| myo-Inositol-trispyrophosphate | NBS-231047 | 100mg | 623552-11-4 / 802590-64-3 / 23103-35-7 |
| Ins(123456)P6 | NBS-231048 | 5g; 25g | 83-86-3 / 14306-25-3 (sodium salt) |
| Ins(23456)P5*10Na | NBS-231049 | 1mg | 109526-12-7 (8Na) / 25663-09-6 (H+) |
| Ins(13456)P5*10Na | NBS-231050 | 1mg | 20298-95-7 (H+) |
| Ins(12456)P5*10Na | NBS-231051 | 1mg | 183075-26-5 / 20298-94-6 (H+) |
| Ins(12356)P5*10Na | NBS-231052 | 1mg | 109526-12-7 (8Na) / 25663-09-6 (H+) |
| Ins(12345)P5*10Na | NBS-231053 | 1mg | 183075-27-6 / 20298-96-8 (H+) |
| Ins(1345)P4*8Na | NBS-231054 | 1mg | 135269-51-1 (H+: 99610-76-1) |
| Ins(136)P3*6Na | NBS-231055 | 1mg | 93133-75-6 (H) |
| Ins(134)P3*6K | NBS-231056 | 1mg; 5mg | 140385-74-6 / 98102-63-7 (H) / 145920-23-6 (6Na) |
| Ins(345)P3*3K | NBS-231057 | 1mg | 348128-32-5 / 112791-62-5 (H) / 348128-47-2 (x*K) |
| Ins(145)P3*6K | NBS-231058 | 5mg | 103476-24-0 / 85166-31-0 (H) |
| Ins(145)P3*3Li | NBS-231059 | 5mg | 129828-69-9 / 85166-31-0 (H) |
| Ins(145)P3*6Na | NBS-231060 | 5mg | 108340-81-4 / 85166-31-0 (H) |
| Ins(135)P3*6Na | NBS-231061 | 1mg | N/A |
| Ins(1245)P4*8Na | NBS-231062 | 1mg | 170715-18-1 (H+: 117142-45-7) |
| Bt3-Ins(356)P3 / PM | NBS-231063 | 1 µmol | N/A |
| Bt3-Ins(346)P3 / PM | NBS-231064 | 1 µmol | 503158-16-5 |
| Bt3-Ins(146)P3 / PM | NBS-231065 | 1 µmol | 503158-17-6 |
| Bt3-Ins(135)P3 / PM | NBS-231066 | 1 µmol | 503158-15-4 |
| Bt2-Ins(3456)P4 / PM | NBS-231067 | 1 µmol | 1233512-98-5 |
| Bt2-Ins(1456)P4 / PM | NBS-231068 | 1 µmol | N/A |
| Bt2-Ins(1345)P4 / PM | NBS-231069 | 1 µmol | 503158-20-1 |
| Bt2-Ins(1356)P4 / AM | NBS-231070 | 1 µmol | 164199-43-3 |
| Bt3-Ins(356)P3 / AM | NBS-231071 | 1 µmol | 164199-42-2 |
| Bt3-Ins(346)P3 / AM | NBS-231072 | 1 µmol | 431900-03-7 |
| Bt3-Ins(146)P3 / AM | NBS-231073 | 1 µmol | 431900-02-6 |
| Bt3-Ins(134)P3 / AM | NBS-231074 | 1 µmol | 205247-51-4 |
| Bt3-Ins(136)P3 / AM | NBS-231075 | 1 µmol | N/A |
| Bt3-Ins(135)P3 / AM | NBS-231076 | 1 µmol | 1258008-22-8 |
| Bt3-Ins(145)P3 / AM | NBS-231077 | 1 µmol | 164007-69-6 (196954-45-7) |
| caged-Ins(145)P3 / PM | NBS-231078 | 10 * 10 µg | 1009832-82-9 |
| caged-Ins(145)P3 / PM | NBS-231079 | 100 µg | 1009832-82-9 |
| caged-Ins(145)P3O6 | NBS-231080 | 100 µg | 887903-55-1 (H+) |
| caged-Ins(145)P3 P4 | NBS-231081 | 100 µg | 119147-20-5 / 132204-31-0 |
| PtdIns(345)P3 | NBS-231082 | 1mg | 165689-82-7 |
| PtdIns(45)P2 | NBS-231083 | 1mg | 120595-88-2 / 213596-15-7 |
| PtdIns(34)P2 | NBS-231084 | 1mg | 165883-85-2 |
| PtdIns(5)P | NBS-231085 | 1mg | 291527-75-8 |
| PtdIns(4)P | NBS-231086 | 1mg | 57606-15-2 |
| PtdIns(3)P | NBS-231087 | 1mg | 165689-81-6 |
| PtdIns(1)P | NBS-231088 | 1mg | 62742-56-7 / 28366-80-5 |
| D-myo-Inositol-1,2-O-cyclohexylidene | NBS-231089 | 1g | 55123-25-6 (rac: 6763-47-9) |
| 23:45-diisopropylidene-myo-Inositol | NBS-231090 | 1g | 211294-75-6 |
| 12:56- diisopropylidene-myo-Inositol | NBS-231091 | 1g | 211294-79-0 |
| D-myo-Inositol-2,3-O-cyclohexylidene | NBS-231092 | 1g | 57029-87-5 |
| 2,3:4,5-Di-O-Iso-1,6-Di-O-Benzyl-Ins | NBS-231093 | 1g | 131233-62-0 / 1266500-90-6 |
| 1,2:5,6-Di-O-Iso-3,4-Di-O-Benzyl-Ins | NBS-231094 | 1g | 131233-62-0 / 1266500-90-6 |
| DEAC-dUTP | NBS-231095 | 25 nmol; 100 nmol | N/A |
| 35-PAPS-TEA | NBS-231096 | 5mg | 936827-87-1 |
| ACPPS-TEA | NBS-231097 | 5mg | 102029-54-9 / 62230-90-4 |
| 25-PAPS-Li | NBS-231098 | 5mg | 62230-89-1 / 102029-54-9 |
| 35-PAPS-Li (CAS: 102029-54-9) | NBS-231099 | 5mg | 102029-54-9 / 482-67-7 (H+) |
| EdUTP-TEA | NBS-231100 | 1mg | 1191275-46-3 |
| EdUTP | NBS-231101 | 1mg | 111289-87-3 |
| 2'-PAP | NBS-231102 | 10mg; 50mg | 3805-37-6 |
| 2'-PAP-Na | NBS-231103 | 10mg; 50mg | 108347-94-0 |
| 3'-PAP-Na | NBS-231104 | 10mg; 50mg | 75431-54-8 |
| 3'-PAP | NBS-231105 | 10mg; 50mg | 1053-73-2 |
| Vancomycin hexapeptide | NBS-231106 | 5mg; 10mg | 115236-65-2 |
| Didechloro Vancomycin | NBS-231107 | 20mg; 100mg | 98510-30-6 |
| Vancomycin Impurity A | NBS-231108 | 20mg; 100mg | 91700-98-0 |
| Vancomycin Impurity D | NBS-231109 | 5mg; 10mg | 101485-50-1 |
| Vancomycin Impurity C | NBS-231110 | 5mg; 10mg | 82198-76-3 |
| Vancomycin Impurity B | NBS-231111 | 20mg; 100mg | 55598-85-1 |
| INO-4995 | NBS-231112 | 1mg; 10mg | 868171-91-9 |
| Podophyllotoxin Derivate | NBS-231113 | 100mg | 6559-91-7 |
| Podophyllotoxin Derivate | NBS-231114 | 10mg | 117507-84-3 |
| Clopidogrel Impurity 4 | NBS-231115 | 100mg | 144457-43-2 |
| Gestodene Impurity E | NBS-231116 | 1mg; 10mg | N/A |
| Fidaxomicin Metabolite OP-1118 | NBS-231117 | 1mg; 10mg | 1030825-28-5 |
| Prasugrel metabolite M6-d3 (stabilzed) | NBS-231118 | 1mg | 1234692-58-0 (without d3) |
| Prasugrel metabolite M6 | NBS-231119 | 10mg | 947530-51-0 |
| Clopidogrel Impurity C | NBS-231120 | 10mg | 1346605-15-9 |
| Clopidogrel Impurity 3 | NBS-231121 | 10mg | 141109-18-4 |
| Prasugrel active metabolite M3 HCl (stabilized) | NBS-231122 | 1mg; 5mg | 1287383-06-5 |
| Fidaxomicin-d7 | NBS-231123 | 1mg; 10mg | 873857-62-6 (unlabeled) |
| Methyl 4-(2-hydroxyethyl)benzoate-13C6,2D (Ring-13C6,Ethyl-1,2-D2) | NBS-231124 | 10mg | N/A |
| Anthracene 13C6 | NBS-231125 | 10mg | 189811-60-7 |
| Phenanthrene 13C6 | NBS-231126 | 10mg | 1189955-53-0 |
| Naphthalene 13C10 | NBS-231127 | 10mg | 219526-41-7 |
| Naphthalene 13C6 | NBS-231128 | 10mg | 1192501-11-3 |
| Prasugrel active metabolite M3-d3 (stabilzed) | NBS-231129 | 1mg; 5mg | 1619986-66-1 / 1226870-93-4 (without HCl) |
| 2-Cyanoethyl N,N-diisopropylchlorophosphoramidite | NBS-231130 | 10g | 89992-70-1 |
| Phosphoramidous acid. N.N-bis(1-methylethyl)-. bis(2-cyanoethyl) ester | NBS-231131 | 5g | 102690-88-0 |
| Phosphoramidous acid, N,N-bis(1-methylethyl)-, bis(phenylmethyl) ester | NBS-231132 | 10g | 108549-23-1 |
| Phosphorodiamidous acid. N.N.N'.N'-tetrakis(1-methylethyl)-. phenylmethyl ester | NBS-231133 | 1g | 108549-21-9 |
| Phosphoramidous acid. N.N-bis(1-methylethyl)-. 2-cyanoethyl [1-(2-nitrophenyl)ethyl] ester) | NBS-231134 | 100mg | 461425-49-0 |
| Dichloro N,N-Diisopropylphosphoramidite | NBS-231135 | 10g | 921-26-6 |
| Phosphoramidous acid. N.N-bis(1-methylethyl)-. bis(9H-fluoren-9-ylmethyl) ester | NBS-231136 | 1g; 5g; 10g | 197709-11-8 |
| Di-tert-butyl chloromethyl phosphate | NBS-231137 | 1g | 229625-50-7 |
| Di-benzyl chloromethyl phosphate | NBS-231138 | 1g | 258516-84-6 |
| Ethyl 2-methyl-3-(trimethylsilyl)cycloprop-2-ene-1-carboxylate | NBS-231139 | 1g | 33002-26-5 |
| NOTA-Evans Blue / NEB | NBS-231140 | 1mg; 10mg | N/A |
| CoA-Cy5 | NBS-231141 | 1mg | N/A |
| CoA-Cy3 | NBS-231142 | 1mg | N/A |
| TMe-OHB-DAZA | NBS-231143 | 1mg; 10mg | 2241024-76-8 |
| NEmo2E | NBS-231144 | 10 µL; 50 µL | N/A |
| NEmo1 | NBS-231145 | 10 µL; 50 µL | N/A |
| Phycocyanobilin-PCB | NBS-231146 | 10mg; 25mg | 20298-86-6 |
| D-Serine-O-phosphate | NBS-231147 | 1g; 5g | 73913-63-0 |
| Ph-CCA-NH2 | NBS-231148 | 250mg | 129179-92-6 |
| Menaquinone 8 / MK 8:8 | NBS-231149 | 100 µg; 500 µg | 523-38-6 |
| Allyl-Maleimide | NBS-231150 | 100mg ; 500mg | 2973-17-3 |
| Nor-cisapride Derivative | NBS-231151 | 100mg; 1g | N/A |
| AlK-L-Lysine-HCl-salt | NBS-231152 | 2g; 5g | 6298-03-9 (H+) // 147529-99-5 (HCl) |
| 4-methyl-2,2-bis(trifluoromethyl)oxazolidin-5-one | NBS-231153 | 1g | 6458-31-7 |
| 3-(5-oxo-2,2-bis(trifluoromethyl)oxazolidin-4-yl)propanoic acid | NBS-231154 | 1g | 6458-51-1 |
| 7-(diethylamino)-4-(hydroxymethyl)-coumarin / DEACM | NBS-231155 | 100mg | 54711-38-5 |
| 3-bromo-4-methyl-7-(diethylamino)-coumarin | NBS-231156 | 100mg | 92295-93-7 |
| Xanthohumol | NBS-231157 | 10mg; 50mg | 6754-58-1 |
| IEPOX 4 | NBS-231158 | 5mg | 1189798-08-0 |
| IEPOX 3 | NBS-231159 | 5mg | 1189798-08-0 |
| 2-C-Methyl-L-Threitol | NBS-231160 | 5mg | 93921-84-7 |
| 2-C-Methyl-D-Threitol | NBS-231161 | 5mg | 310887-92-4 |
| 2-C-Methyl-L-Erythritol | NBS-231162 | 5mg | 93921-83-6 |
| 2-C-Methyl-D-Erythritol | NBS-231163 | 5mg | 58698-37-6 |
| 3-Amino-7-(diethylamino)-coumarine | NBS-231164 | 100mg; 500mg | 817638-67-8 |
| Chloromethylpropionate | NBS-231165 | 1g; 5g | 5402-53-9 |
| 2-(2-fluoro-2-methylpropoxy)-2-methylpropan-1-ol | NBS-231166 | 1g; 10g | 1823357-87-4 |
| 1,4-Di-butyryl-23:56-diisopropylidene-myo-Inositol | NBS-231167 | 0.5g; 1g | 1620222-02-7 |
| 3,6-Di-butyryl-12:45-diisopropylidene-myo-Inositol | NBS-231168 | 0.5g; 1g | 1307298-34-5 |
| Y-27632 | NBS-231169 | 50mg | 146986-50-7 |
| H-1152 | NBS-231170 | 10mg | 45146-2-58-1 |
| 3,4,5,6-Tetra-O-Benzyl-Ins | NBS-231171 | 1g | 24558-77-8 |
| 1,4,5,6-Tetra-O-Benzyl-Ins | NBS-231172 | 1g | 26276-99-3 |
| 2,5-Anhydro-6-azido-6-deoxy-1,3-O-isopropylidene-D-glucitol | NBS-231173 | 1g、5g、10g、25g、Bulk | N/A |
| 4-Azido-4-deoxy-1,6:2,3-dianhydro-β-D-mannopyranose | NBS-231174 | 1g、5g、10g、25g、Bulk | N/A |
| Methyl-3,6-anhydro-7-azido-2,7-dideoxy-4,5-O-isopropylidene-D-alloheptonate | NBS-231175 | 1g、5g、10g、25g、Bulk | N/A |
| 1,4-Anhydro-3-azido-2-O-benzoyl-3-deoxy-D-xylitol | NBS-231176 | 1g、5g、10g、25g、Bulk | N/A |
| 1,4-Anhydro-2-azido-3-O-benzoyl-2-deoxy-D-arabitol | NBS-231177 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,4;3,6-dianhydro-D-glucitol | NBS-231178 | 1g、5g、10g、25g、Bulk | N/A |
| 6-Azido-6-deoxy-1,2,3,4-tetra-O-acetyl-α,β-D-galactopyranose | NBS-231179 | 1g、5g、10g、25g、Bulk | N/A |
| 6-Azido-6-deoxy-1,2,3,4-tetra-O-acetyl-α,β-L-galactopyranose | NBS-231180 | 1g、5g、10g、25g、Bulk | N/A |
| DIBMA free acid | NBS-231181 | 1g、5g、10g、25g、Bulk | N/A |
| DIBMA monosodium salt | NBS-231182 | 1g、5g、10g、25g、Bulk | N/A |
| Glyco-DIBMA | NBS-231183 | 1g、5g、10g、25g、Bulk | N/A |
| n-Octyl α-D-glucopyranoside | NBS-231184 | 1g、5g、10g、25g、Bulk | 29781-80-4 |
| HECAMEG | NBS-231185 | 1g、5g、10g、25g、Bulk | 115457-83-5 |
| n-Hexyl β-D-glucopyranoside | NBS-231186 | 1g、5g、10g、25g、Bulk | 59080-45-4 |
| n-Heptyl β-D-glucopyranoside | NBS-231187 | 1g、5g、10g、25g、Bulk | 78617-12-6 |
| n-Octyl β-D-glucopyranoside | NBS-231188 | 1g、5g、10g、25g、Bulk | 29836-26-8 |
| n-Octyl β-D-glucopyranoside | NBS-231189 | 1g、5g、10g、25g、Bulk | 29836-26-8 |
| n-Nonyl β-D-glucopyranoside | NBS-231190 | 1g、5g、10g、25g、Bulk | 69984-73-2 |
| n-Nonyl β-D-glucopyranoside | NBS-231191 | 1g、5g、10g、25g、Bulk | 69984-73-2 |
| n-Decyl β-D-glucopyranoside (DG) > 99% highly purified | NBS-231192 | 1g、5g、10g、25g、Bulk | 58846-77-8 |
| n-Undecyl β-D-glucopyranoside (UDG) | NBS-231193 | 1g、5g、10g、25g、Bulk | 70005-86-6 |
| n-Dodecyl β-D-glucopyranoside | NBS-231194 | 1g、5g、10g、25g、Bulk | 59122-55-3 |
| 4-trans-(4-trans-Propylcyclohexyl)-cyclohexyl α-maltoside | NBS-231195 | 1g、5g、10g、25g、Bulk | N/A |
| n-Dodecyl α-maltoside | NBS-231196 | 1g、5g、10g、25g、Bulk | 116183-64-3 |
| n-Hexyl β-maltoside | NBS-231197 | 1g、5g、10g、25g、Bulk | 870287-95-9 |
| n-Heptyl β-maltoside | NBS-231198 | 1g、5g、10g、25g、Bulk | N/A |
| n-Octyl β-maltoside | NBS-231199 | 1g、5g、10g、25g、Bulk | 82494-08-4 |
| n-Nonyl β-maltoside | NBS-231200 | 1g、5g、10g、25g、Bulk | 106402-05-5 |
| n-Nonyl β-maltoside | NBS-231201 | 1g、5g、10g、25g、Bulk | 106402-05-5 |
| n-Decyl β-maltoside | NBS-231202 | 1g、5g、10g、25g、Bulk | 82494-09-5 |
| n-Decyl β-maltoside | NBS-231203 | 1g、5g、10g、25g、Bulk | 82494-09-5 |
| n-Undecyl β-maltoside | NBS-231204 | 1g、5g、10g、25g、Bulk | 253678-67-0 |
| n-Undecyl β-maltoside | NBS-231205 | 1g、5g、10g、25g、Bulk | 253678-67-0 |
| n-Dodecyl β-maltoside | NBS-231206 | 1g、5g、10g、25g、Bulk | 69227-93-6 |
| n-Tridecyl β-maltoside | NBS-231207 | 1g、5g、10g、25g、Bulk | 93911-12-7 |
| n-Tridecyl β-maltoside | NBS-231208 | 1g、5g、10g、25g、Bulk | 93911-12-7 |
| n-Tetradecyl β-maltoside | NBS-231209 | 1g、5g、10g、25g、Bulk | 18449-82-6 |
| n-Pentadecyl β-maltoside | NBS-231210 | 1g、5g、10g、25g、Bulk | N/A |
| n-Hexadecyl β-maltoside | NBS-231211 | 1g、5g、10g、25g、Bulk | 98064-96-1 |
| n-Dodecyl β-maltoside | NBS-231212 | 1g、5g、10g、25g、Bulk | 69227-93-6 |
| Isopropyl 1-thio-β-D-galactopyranoside | NBS-231213 | 1g、5g、10g、25g、Bulk | 367-93-1 |
| n-Heptyl 1-thio-β-D-glucopyranoside | NBS-231214 | 1g、5g、10g、25g、Bulk | 85618-20-8 |
| n-Octyl 1-thio-β-D-glucopyranoside | NBS-231215 | 1g、5g、10g、25g、Bulk | 85618-21-9 |
| n-Nonyl 1-thio-β-D-glucopyranoside | NBS-231216 | 1g、5g、10g、25g、Bulk | 98854-15-0 |
| n-Decyl 1-thio-β-D-glucopyranoside | NBS-231217 | 1g、5g、10g、25g、Bulk | 98854-16-1 |
| n-Dodecyl 1-thio-β-maltoside | NBS-231218 | 1g、5g、10g、25g、Bulk | 148565-58-6 |
| n-Heptyl 1-thio-β-D-glucopyranoside | NBS-231219 | 1g、5g、10g、25g、Bulk | 85618-20-8 |
| n-Octyl 1-thio-β-D-glucopyranoside | NBS-231220 | 1g、5g、10g、25g、Bulk | 85618-21-9 |
| MEGA-8 | NBS-231221 | 1g、5g、10g、25g、Bulk | 85316-98-9 |
| MEGA-9 | NBS-231222 | 1g、5g、10g、25g、Bulk | 85261-19-4 |
| MEGA-10 | NBS-231223 | 1g、5g、10g、25g、Bulk | 85261-19-4 |
| 1-O-(n-Octyl)-tetraethyleneglycol | NBS-231224 | 1g、5g、10g、25g、Bulk | 19327-39-0 |
| 1-O-(n-Decyl)-hexaethyleneglycol (C10E6) | NBS-231225 | 1g、5g、10g、25g、Bulk | 5168-89-8 |
| 1-O-(n-Decyl)-nonaethyleneglycol | NBS-231226 | 1g、5g、10g、25g、Bulk | 26183-52-81 |
| 1-O-(n-Dodecyl)-tetraethyleneglycol | NBS-231227 | 1g、5g、10g、25g、Bulk | 5274-68-0 |
| 1-O-(n-Dodecyl)-octaethyleneglycol | NBS-231228 | 1g、5g、10g、25g、Bulk | 3055-98-9 |
| 1-O-(n-Dodecyl)-nonaethyleneglycol | NBS-231229 | 1g、5g、10g、25g、Bulk | 3055-99-0 |
| 1-O-(n-Dodecyl)-decaethyleneglycol | NBS-231230 | 1g、5g、10g、25g、Bulk | 6540-99-4 |
| 1-O-(n-Tridecyl)-octaethyleneglycol | NBS-231231 | 1g、5g、10g、25g、Bulk | 9043-30-5 |
| N,N-Dimethyl-n-dodecylamine-N-oxide | NBS-231232 | 1g、5g、10g、25g、Bulk | 1643-20-5 |
| Sucrose monolaurate | NBS-231233 | 1g、5g、10g、25g、Bulk | 25339-99-5 |
| Monoolein | NBS-231234 | 1g、5g、10g、25g、Bulk | 111-03-5 |
| 3-[(3-Cholamidopropyl)-dimethylammonio]-1-propane sulfonate | NBS-231235 | 1g、5g、10g、25g、Bulk | 75621-03-3 |
| CHAPSO | NBS-231236 | 1g、5g、10g、25g、Bulk | 82473-24-3 |
| n-Nonylphosphocholine | NBS-231237 | 1g、5g、10g、25g、Bulk | 253678-64-7 |
| n-Decylphosphocholine | NBS-231238 | 1g、5g、10g、25g、Bulk | 70504-28-8 |
| n-Undecylphosphocholine | NBS-231239 | 1g、5g、10g、25g、Bulk | 253678-65-8 |
| n-Dodecylphosphocholine | NBS-231240 | 1g、5g、10g、25g、Bulk | 29557-51-5 |
| n-Tridecylphosphocholine | NBS-231241 | 1g、5g、10g、25g、Bulk | 85775-42-4 |
| n-Tetradecylphosphocholine | NBS-231242 | 1g、5g、10g、25g、Bulk | 77733-28-9 |
| n-Pentadecylphosphocholine | NBS-231243 | 1g、5g、10g、25g、Bulk | 146801-07-2 |
| n-Hexadecylphosphocholine | NBS-231244 | 1g、5g、10g、25g、Bulk | 58066-85-6 |
| α-D-Galactopyranose-phosphate di-potassium salt dihydrate | NBS-231245 | 1g、5g、10g、25g、Bulk | 19046-60-7 |
| α-D-Glucopyranose-phosphate di-potassium salt dihydrate | NBS-231246 | 1g、5g、10g、25g、Bulk | 5996-14-5 |
| α-D-Mannopyranose-phosphate di-potassium salt dihydrate | NBS-231247 | 1g、5g、10g、25g、Bulk | 71888-67-0 |
| N-Acetyl-D-galactosamine | NBS-231248 | 1g、5g、10g、25g、Bulk | 1811-31-0 |
| N-Acetyl-D-glucosamine | NBS-231249 | 1g、5g、10g、25g、Bulk | 7512-17-6 |
| 2-Acetamido-2-deoxy-β-D-glucopyranosylamin | NBS-231250 | 1g、5g、10g、25g、Bulk | 18615-50-4 |
| 2-Acetamido-2-deoxy-D-mannose monohydrate | NBS-231251 | 1g、5g、10g、25g、Bulk | 7772-94-3 |
| 1,3,4,6-tetra-O-acetyl-β-D-GlcNAc | NBS-231252 | 1g、5g、10g、25g、Bulk | 7772-79-4 |
| 3,4,6-tri-O-acetyl-β-D-GlcNAc azide | NBS-231253 | 1g、5g、10g、25g、Bulk | 6205-69-2 |
| 3,4,6-tri-O-acetyl-α-D-GlcNAc chlorid | NBS-231254 | 1g、5g、10g、25g、Bulk | 3068-34-6 |
| 1,3,4,6-tetra-O-acetyl-α-D-glucosamine x HCl | NBS-231255 | 1g、5g、10g、25g、Bulk | N/A |
| Allyl 2-acetamido-2-deoxy-α-D-glucopyranoside | NBS-231256 | 1g、5g、10g、25g、Bulk | 54400-75-8 |
| Allyl 2-acetamido-2-deoxy-β-D-glucopyranoside | NBS-231257 | 1g、5g、10g、25g、Bulk | 54400-77-0 |
| Allyl α-D-galactopyranoside | NBS-231258 | 1g、5g、10g、25g、Bulk | 48149-72-0 |
| Allyl α-D-glucopyranoside | NBS-231259 | 1g、5g、10g、25g、Bulk | 7464-56-4 |
| Allyl β-D-glucopyranoside | NBS-231260 | 1g、5g、10g、25g、Bulk | 34384-797 |
| Allyl α-D-mannopyranoside | NBS-231261 | 1g、5g、10g、25g、Bulk | 41308-76-3 |
| Allyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside | NBS-231262 | 1g、5g、10g、25g、Bulk | N/A |
| 1-Amino-1-deoxy-β-D-galactose | NBS-231263 | 1g、5g、10g、25g、Bulk | 50444-86-5 |
| 1,6-Anhydro-β-D-galactopyranose | NBS-231264 | 1g、5g、10g、25g、Bulk | 644-76-8 |
| 1,6:3,4-Dianhydro-2-O-tosyl--D-galactopyranose | NBS-231265 | 1g、5g、10g、25g、Bulk | 6167-32-4 |
| D-Arabinose | NBS-231266 | 1g、5g、10g、25g、Bulk | 28697-53-2 |
| Arbutin | NBS-231267 | 1g、5g、10g、25g、Bulk | 497-76-7 |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-galactopyranose | NBS-231268 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α,β-D-galacto-pyranose | NBS-231269 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucopyranose | NBS-231270 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,2‘,3,3‘,4‘,6,6‘-hepta-O-acetyl-α,β-lactose | NBS-231271 | 1g、5g、10g、25g、Bulk | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-mannopyranose | NBS-231272 | 1g、5g、10g、25g、Bulk | N/A |
| Benzyl 4,6-O-benzylidene-α-D-GlcNAc | NBS-231273 | 1g、5g、10g、25g、Bulk | 13343-63-0 |
| Benzyl 2-acetamido-2-deoxy-α-D-glucopyranoside | NBS-231274 | 1g、5g、10g、25g、Bulk | 13343-62-9 |
| Benzyl α-D-mannopyranoside | NBS-231275 | 1g、5g、10g、25g、Bulk | 155548-45-5 |
| Cellobiose | NBS-231276 | 1g、5g、10g、25g、Bulk | 528-50-7 |
| 6-Deoxy-1,2:3,4-di-O-isopropylidene-α-D-galactopyranose | NBS-231277 | 1g、5g、10g、25g、Bulk | 4026-27-1 |
| 3,4-Di-O-acetyl-L-rhamnal | NBS-231278 | 1g、5g、10g、25g、Bulk | 34819-86-8 |
| 1,4:3,6-Dianhydro-D-mannitol | NBS-231279 | 1g、5g、10g、25g、Bulk | 641-74-7 |
| 1,2,3,4-Di-O-isopropylidene-α-D-galactopyranose | NBS-231280 | 1g、5g、10g、25g、Bulk | 4064-06-6 |
| 1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose | NBS-231281 | 1g、5g、10g、25g、Bulk | 582-52-5 |
| 1,2:5,6-Di-O-isopropylidene-D-mannitol | NBS-231282 | 1g、5g、10g、25g、Bulk | 1707-77-3 |
| 2,3:5,6-Di-O-isopropylidene-α-D-mannofuranose | NBS-231283 | 1g、5g、10g、25g、Bulk | 14131-84-1 |
| 1,2:3,5-Di-O-isopropylidene-α-D-xylofuranose | NBS-231284 | 1g、5g、10g、25g、Bulk | 20881-04-3 |
| D-Fucose | NBS-231285 | 1g、5g、10g、25g、Bulk | 3615-37-0 |
| L-Fucose | NBS-231286 | 1g、5g、10g、25g、Bulk | 2438-80-4 |
| D-Galactosamine x HCl | NBS-231287 | 1g、5g、10g、25g、Bulk | 1172-03-8 |
| D-Glucosamine x HCl | NBS-231288 | 1g、5g、10g、25g、Bulk | 66-84-2 |
| L-Glucose | NBS-231289 | 1g、5g、10g、25g、Bulk | 921-60-8 |
| 2,3,3’,4,6,6’-Hexa-O-acetyl-lactal | NBS-231290 | 1g、5g、10g、25g、Bulk | N/A |
| 1,2-O-Isopropylidene-α-D-glucofuranose | NBS-231291 | 1g、5g、10g、25g、Bulk | 18549-40-1 |
| Isopropyl-β-D-thiogalactoside | NBS-231292 | 1g、5g、10g、25g、Bulk | 367-93-1 |
| Isopropyl-β-D-thiogalactoside | NBS-231293 | 1g、5g、10g、25g、Bulk | 367-93-1 |
| 3,4-O-Isopropylidene-D-mannitol | NBS-231294 | 1g、5g、10g、25g、Bulk | 369-84-4 |
| 1,2-O-Isopropylidene-α-D-xylofuranose | NBS-231295 | 1g、5g、10g、25g、Bulk | 20031-21-4 |
| D-Lyxose | NBS-231296 | 1g、5g、10g、25g、Bulk | 1114-34-7 |
| L-Lyxose | NBS-231297 | 1g、5g、10g、25g、Bulk | 1949-78-6 |
| Maltose monohydrate | NBS-231298 | 1g、5g、10g、25g、Bulk | 6363-53-7 |
| β-Maltose octaacetate | NBS-231299 | 1g、5g、10g、25g、Bulk | 22352-19-8 |
| D-Mannose | NBS-231300 | 1g、5g、10g、25g、Bulk | 3458-28-4 |
| L-Mannose | NBS-231301 | 1g、5g、10g、25g、Bulk | 10030-80-5 |
| Methyl 4,6-O-benzylidene-β-D-galactopyranoside | NBS-231302 | 1g、5g、10g、25g、Bulk | 6988-39-2 |
| Methyl 4,6-O-benzylidene-α-D-glucopyranoside | NBS-231303 | 1g、5g、10g、25g、Bulk | 3162-96-7 |
| Methyl 4,6-O-benzylidene-β-D-glucopyranoside | NBS-231304 | 1g、5g、10g、25g、Bulk | 6988-39-2 |
| Methyl 6-deoxy-α-L-mannopyranoside | NBS-231305 | 1g、5g、10g、25g、Bulk | 15814-59-2 |
| Methyl α-D-fucopyranoside | NBS-231306 | 1g、5g、10g、25g、Bulk | 1128-40-1 |
| Methyl α-L-fucopyranoside | NBS-231307 | 1g、5g、10g、25g、Bulk | 14687-15-1 |
| Methyl β-D-galactopyranoside | NBS-231308 | 1g、5g、10g、25g、Bulk | 1824-94-8 |
| Methyl β-D-glucopyranoside hemihydrate | NBS-231309 | 1g、5g、10g、25g、Bulk | 7000-27-3 |
| Methyl β-D-ribopyranoside | NBS-231310 | 1g、5g、10g、25g、Bulk | 17289-61-1 |
| Methyl 2,3,5-tri-O-benzoyl-α-D-arabinofuranoside | NBS-231311 | 1g、5g、10g、25g、Bulk | N/A |
| 1,2,3,4,6-Penta-O-acetyl-β-D-galactopyranose | NBS-231312 | 1g、5g、10g、25g、Bulk | 4163-60-4 |
| 1,2,3,4,6-Penta-O-acetyl-α-D-mannopyranose | NBS-231313 | 1g、5g、10g、25g、Bulk | 4163-65-9 |
| D-Raffinose pentahydrate | NBS-231314 | 1g、5g、10g、25g、Bulk | 17629-30-0 |
| L-Rhamnose monohydrate | NBS-231315 | 1g、5g、10g、25g、Bulk | 10030-85-0 |
| D-Ribose | NBS-231316 | 1g、5g、10g、25g、Bulk | 50-69-1 |
| L-Ribose | NBS-231317 | 1g、5g、10g、25g、Bulk | 24259-59-4 |
| D-Tagatose | NBS-231318 | 1g、5g、10g、25g、Bulk | 87-81-0 |
| α-D-Talose | NBS-231319 | 1g、5g、10g、25g、Bulk | 2595-98-4 |
| 2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl azide | NBS-231320 | 1g、5g、10g、25g、Bulk | 13992-26-2 |
| 2,3,4,6-Tetra-O-acetyl-α-D-galactopyranosyl bromide | NBS-231321 | 1g、5g、10g、25g、Bulk | 3068-32-4 |
| 2,3,4,6-Tetra-O-acetyl--D-glucopyranosyl azide | NBS-231322 | 1g、5g、10g、25g、Bulk | 13992-25-1 |
| 2,3,4,6-Tetra-O-acetyl-α-D-glucopyranosyl bromide | NBS-231323 | 1g、5g、10g、25g、Bulk | 572-09-8 |
| 1,3,4,6-Tetra-O-acetyl-β-D-mannopyranose | NBS-231324 | 1g、5g、10g、25g、Bulk | 18968-05-3 |
| 2,3,4,6-Tetra-O-acetyl-α-D-mannopyranose | NBS-231325 | 1g、5g、10g、25g、Bulk | N/A |
| 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose | NBS-231326 | 1g、5g、10g、25g、Bulk | 13035-61-5 |
| 2,3,4,6-Tetra-O-acetyl-1-thio-β-D-galactopyranose | NBS-231327 | 1g、5g、10g、25g、Bulk | N/A |
| 2,3,4,6-Tetra-O-acetyl-1-thio-β-D-glucopyranose | NBS-231328 | 1g、5g、10g、25g、Bulk | 19879-84-6 |
| 2,3,4,6-Tetra-O-benzyl-α-D-galactopyranose | NBS-231329 | 1g、5g、10g、25g、Bulk | 5308-25-7 |
| 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranose | NBS-231330 | 1g、5g、10g、25g、Bulk | 4132-28-9 |
| 2,3,4,6-Tetra-O-benzyl-α-D-mannopyranose | NBS-231331 | 1g、5g、10g、25g、Bulk | 61330-61-8 |
| 1-Thio-β-D-galactose sodium salt | NBS-231332 | 1g、5g、10g、25g、Bulk | 42891-22-5 |
| 1-Thio-β-D-glucose sodium salt dihydrate | NBS-231333 | 1g、5g、10g、25g、Bulk | 10593-29-0 |
| 3,4,6-Tri-O-acetyl-D-galactal | NBS-231334 | 1g、5g、10g、25g、Bulk | 4098-06-0 |
| D-Turanose | NBS-231335 | 1g、5g、10g、25g、Bulk | 547-25-1 |
| D-Xylose | NBS-231336 | 1g、5g、10g、25g、Bulk | 58-86-6 |
| 1,6-Anhydro-β-D-glucopyranose | NBS-231337 | 1g、5g、10g、25g、Bulk | 498-07-7 |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-glucopyranose | NBS-231338 | 1g、5g、10g、25g、Bulk | N/A |

艾美捷科技特约代理Everest Biotech公司产品。
Everest Biotech公司成立于2000年,该公司主要生产山羊抗体,针对人类、小鼠、大鼠等物种的一系列重要的抗原。另外,Everest Biotech公司已通过ISO 9001:2015认证 (Certificate number CA14829),可靠的质量和个性化的服务,使得客户以遍布全球。
所有来自Everest Biotech的抗体均有以下特性
(1) Everest Biotech自主研发生产
(2)全部经过肽亲和纯化以保证最佳的特异性和纯度;
(3)经过免疫原肽的ELISA和WB实验验证;
(4)PhD科学家团队,提供全方位技术支持服务。
Everest Biotech - Experts in antigen affinity purified goat polyclonal antibodies.
Since 2000, Everest has been producing a catalog containing thousands of goat antibodies against a broad range of human, mouse and rat proteins of biomedical interest.
Everest Biotech's commitment to quality and continuous improvement has been recognised with ISO 9001:2015 accreditation (Certificate number CA14829). The customers can be assured they will receive high quality product and excellent customer service.
按疾病种类分:
Allergy
Autoimmunity
Cancer
Cardiovascular
Genetic Disorders
Infectious
Metabolic
Neuronal
按生物功能分:
Adhesion
Apoptosis and its regulation
Autophagy
Cell Cycle and DNA Repair
Chromatin, Histone and RNA regulation
CNS and PNS
Cytoskeletal elements
Embryogenesis and cell differentiation
GAP, GBP, GEF. GRP, GTPase proteins
Inflammation
lectins
Lipids and Sterols Pathways
Mitochondrial proteins
Protein integrity, maturation and break down
Protein Kinases
Protein Phosphatases and Inhibitors
Receptors
SH2 domain containing proteins
SH3 domain containing proteins
Transcriptional regulators
Transcription factors
Translation and its regulation
Transporters, protein sorting, channels
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Everest Biotech"> Everest Biotech
Dianova公司为德国著名的病理免疫组化产品供应商,具备领先的抗体制备工艺及严格的质控系统,产品在国际上享有良好的声誉。
Since its foundation in 1982, dianova GmbH provides professionals in Life Sciences with antibodies, immunoassays, and products for molecular biology. More than 30 years of grown expertise give rise to a fundamental knowledge about biochemical applications and a profound understanding of customer needs in research and routine diagnostic laboratories of universities, hospitals and the pharmaceutical industry.
Dianova公司的主要产品包括:
Proteine
Assays / Kits
Reagenzien / Medien
Material
Geräte
Antikörper-Service
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Dianova"> Dianova
艾美捷科技代理Berry & Associates全系列修饰核苷酸等
美国 Berry & Associates 公司成立于1989年,提供近200种亚磷酰胺和核苷酸合成用固相交联单体,以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。
Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.







Berry & Associates的主要产品包括:
| 产品名称 | 产品编号 | 纯度 | 规格 |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2'-3'-Dideoxyguanosine | PR 3505 | ≥95% | 25 mg; 100 mg |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 2',3'-Dideoxyuridine | PY 7278 | ≥97% | 100 mg; 500 mg |
| 2',3'-Didehydro-2',3'-dideoxyuridine | PY 7279 | ≥97% | 25 mg; 100 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| 2-Amino-2'-deoxyadenosine | PR 3060 | ≥97% | 1 g; 5 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine | PR 3080 | ≥95% | 100 mg; 1 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-isobutyryl-2'-deoxyadenosine | PR 3130 | ≥95% | 100 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3670 | ≥95% | 100 mg; 1 g |
| 2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine | PR 3070 | ≥97% | 25 mg; 100 mg |
| 2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine | PR 3160 | ≥97% | 100 mg; 250 mg |
| 2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate | PR 3180 | ≥97% | 25 mg; 100 mg |
| 2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3680 | ≥97% | 100 mg; 1 g |
| 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | PR 3006 | ≥95% | 25 mg; 100 mg |
| 8-Amino-2'-deoxyadenosine | PR 3115 | ≥97% | 10 mg; 100 mg |
| N6-(6-Aminohexyl)-2'-deoxyadenosine | PR 3120 | ≥90% | 100 mg; 1 g |
| 8-Azido-2'-deoxyadenosine | PR 3125 | ≥97% | 10 mg; 100 mg |
| N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine | PR 3230 | ≥95% | 50 mg; 250 mg |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine | PR 3260 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| 8-Benzyloxy-2'-deoxyadenosine | PR 3280 | ≥97% | 100 mg; 1 g |
| 8-Bromo-2'-deoxyadenosine | PR 3290 | ≥90% | 2 g; 10 g |
| 8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3320 | ≥95% | 100 mg; 1 g |
| 8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3340 | ≥97% | 0g (discontinued); |
| 2'-Deoxyadenosine Monohydrate | PR 3445 | ≥97% | 25 g; 100 g |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2-Fluoro-2'-deoxyadenosine | PR 3496 | ≥97% | 25 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| N6-Methyl-2'-deoxyadenosine | PR 3740 | ≥97% | 100 mg; 1 g |
| 4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine | PRA 10012 | ≥95% | 10 mg; 50 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| 7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine | PRA 10032 | ≥95% | 10 mg; 50 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 8-Allyloxy-2'-deoxyguanosine | PR 3010 | ≥90% | 0Discontinued; |
| 8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3015 | ≥90% | 1 g; 10 g |
| 8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3020 | ≥90% | 1 g; 10 g |
| 5'-Azido-5'-deoxyguanosine | PR 3225 | ≥90% | 5 mg; 10 mg |
| 8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3285 | ≥90% | 1 g; 10 g |
| 8-Bromo-2'-deoxyguanosine | PR 3300 | ≥90% | 1 g; 5 g |
| 8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine | PR 3310 | ≥97% | 500 mg; 1 g |
| 8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3330 | ≥90% | 250 mg; 1 g |
| 5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine | PR 3335 | ≥95% | 100 mg; 1 g |
| 2'-Deoxyguanosine monohydrate | PR 3452 | ≥97% | 10 g; 100 g |
| α-2'-Deoxyguanosine | PR 3455 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine | PR 3600 | ≥97% | 100 mg; 1 g |
| 3',5'-Di-O-acetyl-2'-deoxyguanosine | PR 3605 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine | PR 3630 | ≥97% | 100 mg; 1 g |
| N2-Ethyl-2'-deoxyguanosine | PR 3700 | ≥95% | 25 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| N2-Isobutyl-2'-deoxyguanosine | PR 3745 | ≥97% | 10 mg; 100 mg |
| N1-Methyl-2'-deoxyguanosine | PR 3748 | ≥97% | 25 mg; 1 g |
| N2-Methyl-2'-deoxyguanosine | PR 3750 | ≥97% | 25 mg; 100 mg |
| O6-Methyl-2'-deoxyguanosine | PR 3755 | ≥90% | 5 mg; 25 mg |
| 6-Thio-2'-deoxyguanosine | PR 3845 | ≥97% | 10 mg; 100 mg |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 2'-O-Methyladenosine | PR 3734 | ≥97% | 1 g; |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-thiouridine | PY 7575 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-(methylithio)uridine | PY 7577 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine | PR 3000 | ≥97% | 25 mg; 250 mg |
| 3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine | PR 3200 | ≥90% | 50 mg; 250 mg |
| 3'-Azido-2',3'-dideoxyadenosine | PR 3210 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-2',3'-dideoxyguanosine | PR 3220 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| N6-Benzoyl-3'-deoxyadenosine | PR 3240 | ≥97% | 100 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine | PR 3250 | ≥97% | 100 mg; 1 g |
| 3'-Deoxyadenosine | PR 3430 | ≥97% | 10 mg; 100 mg |
| 3'-Deoxyguanosine | PR 3460 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine | PR 3590 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-3'-deoxyguanosine | PR 3690 | ≥97% | 20 mg; 100 mg |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine | PY 7230 | ≥97% | 100 mg; |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3040 | ≥97% | 1 g; |
| 2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3045 | ≥95% | 1 g; |
| 2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine | PR 3050 | ≥95% | 5 g; 25 g |
| 6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3370 | ≥97% | 100 mg; 1 g |
| 6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3380 | ≥90% | 100 mg; 1 g |
| 6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine | PR 3390 | ≥97% | 0 g; |
| 6-Chloro-9-(β-D-ribofuranosyl)purine | PR 3400 | ≥97% | 5 g; 10 g |
| Adenosine | PR 3005 | ≥97% | 100 g; 1 kg |
| 8-Methyladenosine | PR 3007 | ≥95% | 25 mg; 100 mg |
| Vidarabine | PR 3008 | ≥97% | 1 g; 5 g |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| N1-Methyladenosine hydroiodide | PR 3032 | ≥95% | 100 mg; 1 g |
| 2-Methyladenosine | PR 3035 | ≥97% | 10 mg; 25 mg |
| 5'-Chloro-5'-deoxyadenosine | PR 3360 | ≥97% | 100 mg; 1 g |
| N6-Methyladenosine | PR 3732 | ≥97% | 100 mg; 1 g |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10000 | ≥97% | 100 mg; 1 g |
| 2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10005 | ≥97% | 500 mg; 1 g |
| 4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine | PRA 10006 | ≥90% | 25 mg; 100 mg |
| 8-Azaadenosine | PRA 10007 | ≥97% | 20 mg; |
| 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine) | PRA 10008 | ≥95% | 10 mg; 100 mg |
| 4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine | PRA 10009 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-7-deaza-2'-deoxyadenosine | PRA 10010 | ≥97% | 100 mg; 1 g |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; 1 g |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine | PRA 10020 | ≥97% | 100 mg; 1 g |
| 3-Deaza-2'-deoxyadenosine | PRA 10025 | ≥97% | 25 mg; 100 mg |
| 7-Deaza-2'-deoxyadenosine | PRA 10030 | ≥97% | 100 mg; 1 g |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 7-Deaza-2'-deoxyguanosine | PRA 10040 | ≥97% | 100 mg; 1 g |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 7-Deaza-2'-deoxyxanthosine | PRA 10050 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine | PRA 10055 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10100 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10110 | ≥97% | 100 mg; 1 g |
| Sangivamycin | PRA 10140 | ≥97% | 10 mg; 25 mg |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; 100 mg |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| dNaM | FC 8110 | ≥97% | 25 mg; 100 mg |
| 9-Deaza-2'-deoxyguanosine | PRA 10120 | ≥97% | 10 mg; 100 mg |
| 9-Deazaguanosine | PRA 10130 | ≥97% | 10 mg; 100 mg |
| 2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine | PYA 11000 | ≥97% | 10 mg; 25 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| 2'-Deoxypseudoisocytidine | PYA 11005 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudouridine | PYA 11010 | Purity: ≥97% | 25 mg; |
| 5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine | PYA 11035 | Purity: ≥97% | 50 mg; 100 mg |
| 1,3-Dimethyl-2'-deoxypseudouridine | PYA 11040 | ≥97% | 10 mg; 100 mg |
| 1,3-Dimethylpseudouridine | PYA 11050 | ≥97% | 10 mg; 50 mg |
| N1-Methylpseudouridine | PYA 11052 | ≥95% | 10 mg; 50 mg |
| N3-Methylpseudouridine | PYA 11054 | ≥97% | 10 mg; 25 mg |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Pseudoisocytidine hydrochloride | PYA 11060 | ≥97% | 10 mg; 100 mg |
| Pseudothymidine | PYA 11070 | ≥97% | 10 mg; 100 mg |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; 50 mg |
| 3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine | PR 3350 | ≥97% | 10 mg; |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-Deoxy-8,5'-cycloadenosine | PR 3440 | ≥97% | 10 mg; 100 mg |
| 2',5'-Dideoxy-8,5'-cycloadenosine | PR 3500 | ≥97% | 10 mg; |
| 2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine | PR 3730 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-8,5'-cycloadenosine | PR 3800 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-2'-deoxy-8,5'-cycloadenosine | PR 3810 | ≥97% | 10 mg; |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine | PY 7054 | ≥97% | 25 mg; 100 mg |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 5-Bromo-2'-deoxycytidine | PY 7115 | ≥97% | 1 g; 10 g |
| Cytidine | PY 7215 | ≥97% | 50 g; 500 g |
| 2'-Deoxycytidine | PY 7216 | ≥97% | 10 g; 50 g |
| 2'-Deoxycytidine Hydrochloride | PY 7217 | ≥97% | 5 g; 50 g |
| 5'-Azido-2',5'-dideoxycytidine | PY 7219 | ≥97% | 25 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| N4-Ethyl-2'-deoxycytidine | PY 7245 | ≥97% | 100 mg; 250 mg |
| 5-Methyl-2'-deoxyisocytidine | PY 7255 | ≥95% | 500 mg; 1 g |
| 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7270 | ≥97% | 20 mg; 50 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7380 | ≥97% | 50 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine | PY 7410 | ≥97% | 100 mg; |
| 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one | PY 7540 | ≥95% | 250 mg; 500 mg |
| Cytidin-5-yl-methanesulfonate sodium salt hydrate | PY 7586 | ≥95% | 50 mg; 100 mg |
| 5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine | PY 7587 | ≥97% | 10 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxycytidine | PY 7588 | ≥97% | 50 mg; 100 mg |
| 5-Formyl-2'-deoxycytidine | PY 7589 | ≥97% | 5 mg; 10 mg |
| 5-Carboethoxy-2'-deoxycytidine | PY 7592 | ≥95% | 25 mg; 100 mg |
| 2'-Deoxycytidine-5-carboxylic acid, sodium salt | PY 7593 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxymethylcytidine | PY 7596 | ≥97% | 50 mg; 100 mg |
| Cytidine-5-carboxylic acid, sodium salt | PY 7598 | ≥97% | 10 mg; 50 mg |
| 5-Formylcytidine | PY 7599 | ≥97% | 5 mg; 10 mg |
| 5-Iodo-2'-deoxycytidine | PY 7607 | ≥97% | 2 g; 10 g |
| 5-Iodocytidine | PY 7609 | ≥97% | 5 g; |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Methyl-2'-deoxycytidine Hydrochloride | PY 7635 | ≥97% | 0.25 g; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methylcytidine | PY 7637 | ≥97% | 1 g; 5 g |
| N4-Methylcytidine | PY 7638 | ≥97% | 25 mg; 100 mg |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 2-Thiocytidine | PY 7721 | ≥97% | 10 mg; 100 mg |
| 2-Thio-2'-deoxycytidine | PY 7723 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| 8-Hydroxyguanosine | PR 3795 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 5-Aza-2'-deoxycytidine | PY 7105 | ≥95% | 25 mg; 100 mg |
| 5,6-Dihydro-5-aza-2'-deoxycytidine | PY 7106 | ≥97% | 25 mg; 100 mg |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| Nap-dU | PY 7735 | ≥97% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 8-18O-Hydroxyguanosine | IOPR 3795 | ≥95% | 2 mg; 5 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| N2-Dimethylguanosine | PR 3702 | ≥97% | 10 mg; 100 mg |
| Guanosine | PR 3703 | ≥97% | 100 g; 500 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| O6-Methylguanosine | PR 3757 | ≥97% | 25 mg; 100 mg |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 8-Bromoguanosine | PR 3796 | ≥97% | 0 g; |
| 8-Benzyloxyguanosine | PR 3797 | ≥95% | 100 mg; 1 g |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 2'-Deoxy-4-desmethylwyosine | PR 3450 | ≥95% | 100 mg; 500 mg |
| 2'-Deoxyinosine | PR 3463 | ≥97% | 10 g; 100 g |
| 5'-Azido-2',5'-dideoxyinosine | PR 3464 | ≥97% | 5 mg; 25 mg |
| 3',5'-Di-O-acetyl-2'-deoxyinosine | PR 3480 | ≥97% | 1 g; |
| 3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine | PR 3490 | ≥90% | 1 g; |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| 5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine | PR 3660 | ≥97% | 100 mg; 1 g |
| Inosine | PR 3725 | ≥97% | 100 g; 500 g |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| O6-Phenyl-2'-deoxyinosine | PR 3840 | ≥97% | 100 mg; 1 g |
| 2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3842 | ≥97% | 25 mg; |
| 5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3843 | ≥90% | 25 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine | PR 3510 | ≥90% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3520 | ≥95% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3530 | ≥90% | 100 mg; 1 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| d5SICS | FC 8120 | ≥97% | 25 mg; 100 mg |
| AICA Riboside (AICAR) | MN 20001 | ≥97% | 0 g (DISCONTINUED); |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine | PR 3692 | ≥95% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| tC Nucleoside | PYA 11110 | ≥97% | 50 mg; 100 mg |
| tCnitro Nucleoside | PYA 11115 | ≥95% | 5 mg; 25 mg |
| 2'-Deoxynebularine | PR 3470 | Purity: ≥97% | 100 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole | PYA 11020 | ≥97% | 50 mg; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole | PYA 11030 | ≥95% | 100 mg; |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; |
| 5'-Amino-5'-deoxythymidine | PY 7030 | ≥97% | 25 mg; 50 mg |
| O2,5'-Anhydrothymidine | PY 7060 | ≥95% | 500 mg; 1 g |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 5'-Azido-5'-deoxythymidine | PY 7070 | ≥97% | 25 mg; 100 mg |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7120 | ≥97% | 1 g; |
| 3'-O-(t-Butyldimethylsilyl)thymidine | PY 7130 | ≥95% | 500 mg; 1 g |
| 5'-O-(t-Butyldimethylsilyl)thymidine | PY 7140 | ≥97% | 5 g; 10 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)thymidine | PY 7150 | ≥97% | 1 g; 5 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine | PY 7160 | ≥95% | 100 mg; 500 mg |
| S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine | PY 7200 | ≥95% | 10 mg; 100 mg |
| S4-(2-Cyanoethyl)-4-thiothymidine | PY 7210 | ≥95% | 10 mg; 100 mg |
| 5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7250 | ≥97% | 1 g; |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one | PY 7315 | ≥90% | 1 g; 10 g |
| 2',3'-Didehydro-3'-deoxythymidine | PY 7328 | ≥95% | 10 mg; 100 mg |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| 5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine | PY 7510 | ≥97% | 50 mg; 100 mg |
| 2-O-Ethylthymidine | PY 7561 | ≥97% | 500 mg; 1 g |
| 5'-Iodo-5'-deoxythymidine | PY 7610 | ≥97% | 250 mg; 1 g |
| 5'-O-Methylthymidine | PY 7680 | ≥95% | 50 mg; 100 mg |
| 2-Thiothymidine | PY 7725 | ≥95% | 20 mg; 100 mg |
| Thymidine | PY 7727 | ≥97% | 25 g; 250 g |
| 5'-O-(p-Toluenesulfonyl)thymidine | PY 7740 | ≥97% | 5 g; |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5'-Trifluoroacetamido-5'-deoxythymidine | PY 7750 | ≥97% | 50 mg; |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 6-Azathymidine | PYA 11058 | ≥95% | 25 mg; 100 mg |
| NPOM-Caged-dT CEP | BA 0317 | ≥95% | 100 µmol; 0.25 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 5-Ethynyl uridine CEP | BA 0353 | ≥90% | 100 µmol; 0.25 g |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 5-(Furan-2-yl)-2'-deoxyuridine | PY 7053 | ≥97% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one | PY 7055 | ≥97% | 20 mg; 100 mg |
| 5-Bromo-2'-deoxyuridine | PY 7117 | ≥97% | 10 g; 25 g |
| 5-Bromouridine | PY 7118 | ≥95% | 5 g; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carbomethoxyvinyl)uridine | PY 7172 | ≥97% | 25 mg; 250 mg |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)uridine | PY 7185 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine | PY 7212 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 2'-Deoxyuridine | PY 7275 | ≥97% | 25 g; 100 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine | PY 7280 | ≥95% | 100 mg; 500 mg |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7310 | ≥97% | 20 mg; 50 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine | PY 7450 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5-Methoxymethyl-2'-deoxyuridine | PY 7465 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-Ethynyl-2'-deoxyuridine | PY 7562 | ≥97% | 25 mg; 100 mg |
| 5-Ethynyl uridine | PY 7563 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-deoxyuridine | PY 7565 | ≥97% | 100 mg; 1 g |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7580 | ≥97% | 25 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7590 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Acetoxymethyl-2'-deoxyuridine | PY 7604 | ≥97% | 25 mg; 100 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 2'-Fluoro-5'-iodo deoxyuridine | PY 7612 | ≥95% | 100 mg; |
| 5-Iodo-2'-deoxyuridine | PY 7615 | ≥97% | 10 g; 25 g |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 5-Iodouridine | PY 7632 | ≥95% | 5 g; 25 g |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 3-Methyluridine | PY 7694 | ≥97% | 25 mg; 100 mg |
| 5-Methyluridine | PY 7695 | ≥97% | 200 mg; 1 g |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 5-(Propargyloxy)-2'-deoxyuridine | PY 7712 | ≥95% | 10 mg; 100 mg |
| Zebularine | PY 7715 | ≥97% | 10 mg; 25 mg |
| 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine | PY 7720 | ≥90% | 500 mg; 1 g |
| 2-Thiouridine | PY 7724 | ≥97% | 25 mg; 100 mg |
| 5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine | PY 7730 | ≥97% | 1 g; 5 g |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine | PY 7758 | ≥97% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| 5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine | PY 7775 | ≥97% | 100 mg; 1 g |
| Uridine | PY 7780 | ≥97% | 100 g; 500 g |
| 2'3'-O-Isopropylidene uridine | PY 7781 | ≥97% | 5 g; 25 g |
| 5-Hydroxymethyl uridine | PY 7782 | ≥97% | 50 mg; 100 mg |
| 5-Methoxyuridine | PY 7783 | ≥97% | 10 mg; 50 mg |
| 6-Aza-2'-deoxyuridine | PYA 11057 | ≥95% | 50 mg; 100 mg |
" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸

Tocris Bioscience是一家专卖生命科学研究chemicals, peptides and antibodies的知名品牌,其产品也广为各大药厂、大学、研究机构,超过五万名科学研究者所采用。 目前,產品內容已超過一千六百種以上,並每年持續不斷的增加新的產品。目前,产品内容已超过一千六百种以上,并每年持续不断的增加新的产品。
Tocris bioscience是位于英国布里斯托尔(Bristol)的高品质试剂提供商,共有2000多种产品,主要集中在神经科学和信号传导领域,产品类型包括小分子、多肽、抗体、配体和化合物筛选文库等,主要产品包括GPCR ligands,神经传递素,离子通道调控剂,信号通路抑制剂等,这些产品被广泛选择性地用于阻断或激活生物学通路。Tocris是世界上神经科学研究领域无可争议的领导者,其生产的影响神经系统的化学物质被多次引用,这些物质很多都来自Jeff Watkins(Tocris 的创立人)在Bristol大学原创性的研究工作。
Tocris Bioscience的主要产品包括:
Small Molecules
Peptides
Aptamers
Controlled Substances
Compound Libraries
DREADD Ligands
Fluorescent Imaging
Ligand Sets
Optopharmacology
Reagents
Toxins
按照研究领域细分:
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Tocris Bioscience"> Tocris Bioscience
艾美捷科技代理Revmab Bioscience品牌。
Revmab Bioscience是一家专注于单克隆抗体药物研发和生产的生物技术公司。公司致力于通过创新的生物技术手段,开发高效、安全的抗体药物,用于治疗自身免疫疾病和感染性疾病。Revmab Bioscience采用高效表达系统,确保抗体的高产量和高纯度;拥有先进的生产工艺和质量控制体系,确保产品的稳定性和一致性;同时具备创新研发能,能够快速开发新型抗体药物。
Revmab公司可提供的产品包括:
(1)单克隆抗体药物:提供多种单克隆抗体药物,用于癌症、自身免疫疾病和感染性疾病的治疗。
(2)生物类似药:开发和生产的生物类似药,用于多种疾病的治疗。
(3)抗体药物偶联物(ADC):提供抗体药物偶联物,用于靶向治疗癌症。
(4)定制抗体开发:根据客户需求,提供定制化的抗体开发服务。
<<< " data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Revmab Bioscience品牌"> 艾美捷科技代理Revmab Bioscience品牌

USBiological位于美国迈阿密Salem,产品包括抗体、生化试剂、细胞生物学试剂、分子生物学试剂和研究用试剂盒。
United States Biological (USBiological) is located in Swampscott in Massachusetts, USA. It's production capabilities include antibiotics, antibodies, agarose, albumin, amino acids, biochemicals, biologicals, cytokines, enzymes, media, molecular biology kits, peptides and serum. All products are supplied with certified testing results. USBio provides a huge selection of antibodies.
USBiological的主要产品包括:
(1)Antibody Catalog
Primary Antibodies
Secondary Antibodies
Isotype Controls
Epitope Tags
Matched Pair Antibody Sets
Custom Antibodies
(2)Biochemical Catalog
Amino Acids
Antibiotics & Antimycotics
Drugs & Analogues
Dyes & Stains
Fine Chemicals
Inorganics
Isotopes
Molecular Biology
Phytochemicals
(3)Biologicals Catalog
Cells & Lysates
Plasma & Serum
Tissues
(4)Cell Culture Media
Culture Media
Insect Media
Microbiological Media
Molecular Biology Media
Nematode Media
pEX™ Protein Expression
Plant Media
Yeast Media/Drop-out
(5)Molecular Biology Catalog
Cloning
Custom
Enzymes
Glycobiology
Growth Factors/Cytokines
Immunoglobulins
Infectious Disease
Lectins
Peptides
Proteins
Separation Detection
(6)Research Kits Catalog
Antibody Sets
Apoptosis
Cell Growth, Axol™
Cloning & PCR
Custom
DNA & RNA Purification
ELISA
Electrochemiluminescence
Immunohistochemistry
Immunoprecipitation
Molecular Biology
Western Blot
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://bio-helix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="USBiological"> USBiological地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:15172469628
传真:18372041646
邮箱:sales@amyjet.com
0.3569